Search for: "Takeda Chemical Industries, Ltd."
Results 1 - 13
of 13
Sorted by Relevance
|
Sort by Date
11 Feb 2007, 6:51 am
., Takeda Chemical Industries, Ltd. and Wako Pure Chemical Industries, Ltd. v. [read post]
28 Jun 2007, 9:36 pm
Takeda Chemical Industries, Ltd. v. [read post]
1 Jul 2007, 11:53 pm
In Takeda Chemical Industries, LTD., et al. v. [read post]
7 May 2012, 10:51 am
Cir. 2012) Download 11-1126Panel: Lourie (author), Moore, Reyna This opinion addresses the appropriateness of using a "lead compound" analytical framework for evaluating the obviousness of chemical compounds, reaffirming and refining the approach taken in Takeda Chemical Industries, Ltd. v. [read post]
4 Sep 2012, 7:38 am
In its ruling, the Federal Circuit reaffirmed the lead compound analysis, employed in Takeda Chemical Industries and Eisai Co. v. [read post]
1 Apr 2008, 2:32 am
In deciding whether to grant the SPC, the question arose as to whether the combination product in question was "protected" by a basic patent in force, as is required by Article 3(a) of Council Regulation 1768/92.Following the decision in Takeda Chemical Industries Ltd's SPC Applications (No.3) [2004] RPC 3, the Hearing Officer confirmed that what amounts to an infringement of the basic patent does not equate to what is protected by the basic patent.… [read post]
27 Mar 2007, 1:18 am
DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKAttorney's Fees$16.8 Million in Fees Awarded Company Winning Suit Over Patent Infringement by Generic Drug Makers Takeda Chemical Industries Inc. v. [read post]
27 Sep 2009, 5:13 pm
Takeda Chemical Industries, Ltd., et al. [read post]
24 Sep 2010, 1:15 pm
Takeda Chemical Industries, Ltd. v. [read post]
13 May 2010, 4:58 pm
Ltd. et al. v. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
13 Jun 2008, 3:40 am
, (IPKat), (IPKat), (Class 46), (IPKat), (IP Law360), Quanta – Supreme Court reverses CAFC decision in Quanta v LG Electronics; method patents exhaustible: (Peter Zura's 271 Patent Blog), (IP Updates), (Hal Wegner), (Patently-O), (Techdirt), (Patent Prospector), (Ars Technica), (Patent Docs), (Agricultural Law Blog), (Filewrapper), (Intellectual Property Law Blog), (Philip Brooks), (Philip Brooks guest blog), (IP ThinkTank), (Electronic Frontier Foundation), (IAM), (IAM), (IPBiz),… [read post]
